KIR2DL3 and chronic obstructive pulmonary disease: found increased inhibitory receptor CD158a+and CD158b+ PB NK cells in COPD patients, which were negatively correlated with pulmonary function, indicating that NK cell inhibitory receptors may contribute to COPD progression (69).